Changeux J
J Biol Chem. 2012; 287(48):40207-15.
PMID: 23038257
PMC: 3504736.
DOI: 10.1074/jbc.R112.407668.
Maggi L, Palma E, Eusebi F, Moretti M, Balestra B, Clementi F
Br J Pharmacol. 1999; 126(1):285-95.
PMID: 10051147
PMC: 1565803.
DOI: 10.1038/sj.bjp.0702299.
Gurney A, Rang H
Br J Pharmacol. 1997; 120(4 Suppl):471-90; discussion 468-9.
PMID: 9142425
PMC: 3224332.
DOI: 10.1111/j.1476-5381.1997.tb06837.x.
Pallotta B, Webb G
J Gen Physiol. 1980; 75(6):693-708.
PMID: 7391813
PMC: 2215267.
DOI: 10.1085/jgp.75.6.693.
Anis N, Clark R, Gration K, Usherwood P
J Physiol. 1981; 312:345-64.
PMID: 7264998
PMC: 1275557.
DOI: 10.1113/jphysiol.1981.sp013632.
The effect of tubocurarine competition on the kinetics of agonist action on the nicotinic receptor.
Colquhoun D, Sheridan R
Br J Pharmacol. 1982; 75(1):77-86.
PMID: 6978750
PMC: 2071444.
DOI: 10.1111/j.1476-5381.1982.tb08759.x.
Interaction between nerve-related acetylcholine and bath applied agonists at the frog end-plate.
Feltz A, Trautmann A
J Physiol. 1980; 299:533-52.
PMID: 6966689
PMC: 1279241.
DOI: 10.1113/jphysiol.1980.sp013141.
Spontaneous openings of the acetylcholine receptor channel.
Jackson M
Proc Natl Acad Sci U S A. 1984; 81(12):3901-4.
PMID: 6328531
PMC: 345330.
DOI: 10.1073/pnas.81.12.3901.
End-plate channel opening and the kinetics of quinacrine (mepacrine) block.
Adams P, Feltz A
J Physiol. 1980; 306:283-306.
PMID: 6257897
PMC: 1283006.
DOI: 10.1113/jphysiol.1980.sp013397.
The channel-blocking action of methonium compounds on rat submandibular ganglion cells.
Gurney A, Rang H
Br J Pharmacol. 1984; 82(3):623-42.
PMID: 6146366
PMC: 1987010.
DOI: 10.1111/j.1476-5381.1984.tb10801.x.
The interaction between hexamethonium and tubocurarine on the rat neuromuscular junction.
Rang H, Rylett R
Br J Pharmacol. 1984; 81(3):519-31.
PMID: 6141831
PMC: 1986851.
DOI: 10.1111/j.1476-5381.1984.tb10105.x.
Immunochemical and pharmacological distinctions between curaremimetic neurotoxin binding sites of central, autonomic, and peripheral origin.
Lukas R
Proc Natl Acad Sci U S A. 1986; 83(15):5741-5.
PMID: 3461458
PMC: 386365.
DOI: 10.1073/pnas.83.15.5741.
Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators.
Ochoa E, Chattopadhyay A, McNamee M
Cell Mol Neurobiol. 1989; 9(2):141-78.
PMID: 2663167
PMC: 11567434.
DOI: 10.1007/BF00713026.
Kinetics of unliganded acetylcholine receptor channel gating.
Jackson M
Biophys J. 1986; 49(3):663-72.
PMID: 2421793
PMC: 1329513.
DOI: 10.1016/S0006-3495(86)83693-1.
Modes of hexamethonium action on acetylcholine receptor channels in frog skeletal muscle.
Adams D, Bevan S, Terrar D
Br J Pharmacol. 1991; 102(1):135-45.
PMID: 1710523
PMC: 1917913.
DOI: 10.1111/j.1476-5381.1991.tb12144.x.
Voltage clamp analysis of acetylcholine receptor desensitization in isolated mollusc neurones.
Bregestovksi P, Bukharaeva E, Iljin V
J Physiol. 1979; 297(0):581-95.
PMID: 536923
PMC: 1458738.
DOI: 10.1113/jphysiol.1979.sp013058.
Interaction of di-iodinated 125I-labelled alpha-bungarotoxin and reversible cholinergic ligands with intact synaptic acetylcholine receptors on isolated skeletal-muscle fibres from the rat.
Darveniza P, Morgan-Hughes J, Thompson E
Biochem J. 1979; 181(3):545-57.
PMID: 518540
PMC: 1161194.
DOI: 10.1042/bj1810545.
An analysis of the dose-response relationship at voltage-clamped frog neuromuscular junctions.
Dionne V, Steinbach J, Stevens C
J Physiol. 1978; 281:421-44.
PMID: 309004
PMC: 1282706.
DOI: 10.1113/jphysiol.1978.sp012431.
The kinetics of tubocurarine action and restricted diffusion within the synaptic cleft.
Armstrong D, Lester H
J Physiol. 1979; 294:365-86.
PMID: 229214
PMC: 1280562.
DOI: 10.1113/jphysiol.1979.sp012935.
